---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-023779"
form_type: "8-K"
ticker: "WGS"
cik: "0001818331"
company_name: "GeneDx Holdings Corp."
filed_at: "2022-08-26T23:59:59+00:00"
generated_at: "2026-06-23T21:06:36.222824+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Sema4 names Kevin Feeley CFO as interim CFO Richard Miao departs

## Summary
- Interim CFO Richard Miao leaves Sept 2, 2022; entitled to accrued compensation.
- Kevin Feeley appointed CFO effective Aug 25, 2022; also SVP of Operations and Head of GeneDx.
- Feeley receives $450k base salary, 50% target bonus, and $750k equity grant.
- Company files updated GeneDx combined financials for Q1 2022 and pro forma for H1 2022.

## SEC filing metadata
- accession: 0001628280-22-023779
- form_type: 8-K
- ticker: WGS
- cik: 0001818331
- company_name: GeneDx Holdings Corp.
- filed_at: 2022-08-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818331/000162828022023779/0001628280-22-023779-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818331/000162828022023779/smfr-20220825.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-023779
- JSON: https://secwatch.observer/filing/0001628280-22-023779.json
- Plain text: https://secwatch.observer/filing/0001628280-22-023779.txt

## Key facts
- Executive change
  Kevin Feeley was appointed as Chief Financial Officer at GeneDx Holdings Corp..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On August 25, 2022, Kevin Feeley, the Company’s current Senior Vice President of Operations and Head of GeneDx, was appointed to also serve as the Chief Financial Officer, effective August 25, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818331/000162828022023779/0001628280-22-023779-index.htm
- Executive change
  Richard Miao departed as Interim Chief Financial Officer and Deputy Chief Financial Officer at GeneDx Holdings Corp..
  - Action: will leave
  - Role: Interim Chief Financial Officer and Deputy Chief Financial Officer
  source text: On August 26, 2022, Sema4 Holdings Corp. (“Sema4 Holdings” or the “Company”) announced that its Interim Chief Financial Officer and Deputy Chief Financial Officer, Richard Miao, will leave the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818331/000162828022023779/0001628280-22-023779-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.